SCHEMBL34064

SCHEMBL34064

CCCCON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27467838 0.97
Hydrochloric Acid SCHEMBL242691 0.97
Water SCHEMBL7771007 0.97 ADRB2 (0.93)
Water SCHEMBL28206764 0.97
Ammonia Solution, Strong SCHEMBL8753117 0.97
Hydrochloric Acid SCHEMBL8752852 0.94
Hydroxyamine SCHEMBL8542475 0.91 ADRB2 (0.82)
Bromide SCHEMBL29119738 0.91
Bromide SCHEMBL29119740 0.91
SCHEMBL184180 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2725 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570890-B2 Additives for well treatment, methods for preparing well treatment composition using these additives, and applications of said composition CAMERON INTERNATIONAL CORPORATION (US) 2026-03-10 US claimed
US-20250360149-A1 GPCR INHIBITORS AND USES THEREOF GPCR THERAPEUTICS INC (KR) 2025-11-27 US claimed
US-20250297153-A1 ADDITIVES FOR WELL TREATMENT, METHODS FOR PREPARING WELL TREATMENT COMPOSITION USING THESE ADDITIVES, AND APPLICATIONS OF SAID COMPOSITION CAMERON INTERNATIONAL CORPORATION 2025-09-25 US claimed
WO-2025092300-A1 USE OF ADRENORECEPTOR AGONISTS IN PROMOTING HEMATOPOIETIC REGENERATION NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2025-05-08 WO claimed
EP-4536239-A1 GPCR INHIBITORS AND USES THEREOF GPCR Therapeutics, Inc. (KR) 2025-04-16 EP claimed
CN-119828414-A Black photoresist composition, preparation method and application thereof 深圳市容大感光科技股份有限公司 2025-04-15 CN claimed
EP-4526395-A1 ADDITIVES FOR WELL TREATMENT, METHODS FOR PREPARING WELL TREATMENT COMPOSITION USING THESE ADDITIVES, AND APPLICATIONS OF SAID COMPOSITION Cameron Technologies Limited (NL) 2025-03-26 EP claimed
WO-2025050038-A2 GPCR INHIBITORS AND USES THEREOF GPCR THERAPEUTICS, INC. (KR) 2025-03-06 WO claimed
CN-119562815-A GPCR inhibitors and uses thereof GPCR治疗公司 2025-03-04 CN claimed
WO-2025034510-A1 ADRENERGIC ANTAGONISTS FOR USE IN A METHOD FOR TREATING CEREBRAL EDEMA OR A BRAIN INJURY UNIVERSITY OF ROCHESTER (US) 2025-02-13 WO claimed
EP-0197718-A2 New medicaments for topical use FIDIA S.p.A. (IT) 1986-10-15 EP claimed
EP-0154009-A1 Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament Euro-Celtique S.A. (LU) 1985-09-11 EP claimed
EP-0073819-A4 NASAL ADMINISTRATION OF BETA-BLOCKERS AND DOSAGE FORMS THEREFOR. UNIV KENTUCKY RES FOUND (US) 1984-11-16 EP claimed
US-4428883-A NASAL OINTMENTS OR GELS THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1984-01-31 US claimed
EP-0073819-A1 NASAL ADMINISTRATION OF BETA-BLOCKERS AND DOSAGE FORMS THEREFOR. UNIV KENTUCKY RES FOUND (US) 1983-03-16 EP claimed
WO-1982003009-A1 NASAL ADMINISTRATION OF BETA-BLOCKERS AND DOSAGE FORMS THEREFOR UNIV KENTUCKY RES FOUND (US) 1982-09-16 WO claimed
US-4311685-A Assay method and kit BURROUGHS WELLCOME CO. (US) 1982-01-19 US claimed
EP-0037622-A2 Drug delivery insert for controlled ocular therapy ALZA CORPORATION (US) 1981-10-14 EP claimed
US-4281654-A Drug delivery system for controlled ocular therapy ALZA CORPORATION (US) 1981-08-04 US claimed
US-4248853-A FOR RAPID DETERMINATION OF ADRENERGIC BLOCKING AGENT IN PATIENTS BY MEASURING THE AMOUNT OF RADIOACTIVE BINDER ON THE RECEPTOR MATERIAL Snyder, Solomon Halbert (US) 1981-02-03 US claimed